Population-based incidence rates of colorectal neoplasms (2000 - 2006) - Has systematic colonoscopy screening an impact on incidence? A combined analysis of cancer registry data of the federal states of Bremen, Hamburg, Saarland and Schleswig-Holstein;Bevölkerungsbezogene Darmkrebsinzidenz im Zeitraum 2000 bis 2006 - Deuten sich erste Auswirkungen des Koloskopie-Screenings an? Eine gemeinsame Auswertung der Krebsregisterdaten aus Bremen, Hamburg, dem Saarland und Schleswig-Holstein

Zeitschrift fur Gastroenterologie

Volumn 48, Issue 12, 2010, Pages 1358-1366

  Waldmann, A ^a   Eberle, A ^b   Hentschel, S ^c   Holleczek, B ^d   Katalinic, A ^a,e  

^a Institut für Krebsepidemiologie E V   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c Hamburgisches Krebsregister   (Germany)

^d Epidemiologisches Krebsregister Saarland   (Germany)

^e Registerstelle des Krebsregisters Schleswig Holstein   (Germany)

Author keywords

colorectal carcinoma; coloscopy screening; incidence; mortality

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CARCINOMA IN SITU; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; GERMANY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; QUALITY CONTROL; RECTUM CANCER;

ADULT; AGED; CARCINOMA IN SITU; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; REGISTRIES; SURVIVAL RATE; UTILIZATION REVIEW;

EID: 78650129317     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245602     Document Type: Article

References (39)

1. Robert Koch-Institut und Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland 2005 2006. Häufigkeiten und Trends. Robert Koch-Institut Berlin 2010
2. Robert Koch-Institut und Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland 2003 2004. Häufigkeiten und Trends. Robert Koch-Institut Berlin 2008
3. Schmiegel W, Adler G, Fruhmorgen P et al. Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung Vorsorge bei Risikopatienten Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen. (Colorectal carcinoma: prevention and early detection in an asymptomatic population prevention in patients at risk endoscopic diagnosis, therapy and after-care of polyps and carcinomas. German Society of Digestive and Metabolic Diseases/Study Group for Gastrointestinal Oncology). Z Gastroenterol 2000 38 49-75
4. Schmiegel W, Pox C, Adler G et al. S3-Leitlinienkonferenz Kolorektales Karzinom 2004. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (Hrsg.). Dtsch Med Wochenschr 2005 130 S5-S53
5. www.uptodate.com. Elektronisches Medizinisches Lehrbuch. http://www.uptodate.com letzter Zugang am 9.4.2008
6. Pox C, Schmiegel W, Classen M. Current status of screening colonoscopy in Europe and in the United States. Endoscopy 2007 39 168-173
7. Mansmann U, Crispin A, Henschel V et al. Bilanz der Qualitä tssicherung ambulanter Koloskopien nach 245 000 Untersuchungen. Deutsches Ärzteblatt 2008 105 434-440
8. Altenhofen L, Heringer M, Blaschy S et al. Projekt wissenschaftliche Begleitung von Früherkennungs-Koloskopien in Deutschland. Berichtszeitraum 2007 5. Jahresbericht. Version 1.1. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland Berlin 2009
9. Benson V S., Patnick J, Davies A K. et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008 122 1357-1367
10. Kaiser Familiy Foundation. United States: Medicare Enrollments. http://www.statehealthfacts.org/profileind.jsp?sub=74&rgn=1&cat=6, eingesehen am 12.2.2010
11. Demographics of the United States. http://en.wikipedia.org/wiki/ Demographics-of-the-United-States eingesehen am 12.2.2010
12. Götzsche P C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2006 18 CD 001877
13. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008 103 1541-1549
14. Andriole G L., Crawford E D., Grubb 3 rd R L. et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009 360 1310-1319
15. Schroder F H., Hugosson J, Roobol M J. et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009 360 1320-1328
16. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 2009 45 2027-2033
17. Boyl P, Levin B. World Cancer Report 2008. WHO/AIRC Lyon 2009
18. Brenner H, Arndt V, Sturmer T et al. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001 85 972-976
19. Citarda F, Tomaselli G, Capocaccia R et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001 48 812-815
20. Costantini A S., Martini A, Puliti D et al. Colorectal cancer mortality in two areas of Tuscany with different screening exposures. J Natl Cancer Inst 2008 100 1818-1821
21. Ellul P, Fogden E, Simpson C L. et al. Downstaging of Colorectal Cancer by the National Bowel Cancer Screening Programme in England: First round data from the first centre. Colorectal Dis 2009 12 420-422
22. Jorgensen O D., Kronborg O, Fenger C et al. Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas). Acta Oncol 2007 46 355-360
23. Thiis-Evensen E, Hoff G S., Sauar J et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999 34 414-420
24. Thiis-Evensen E, Hoff G S., Sauar J et al. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Am J Gastroenterol 2001 96 1901-1907
25. Winawer S J., Zauber A G., Ho M N. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993 329 1977-1981
26. Winawer S J., Zauber A G., OBrien M J. et al. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 1992 70 1236-1245
27. Winawer S J., Zauber A G., OBrien M J. et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993 328 901-906
28. Brenner H, Arndt V, Stegmaier C et al. Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages. Eur J Cancer Prev 2005 14 231-237
29. National Cancer Institute. Surveillance Epidemiology and End Results (SEER). Cancer Statistics. 2010 http://seer.cancer.gov/faststats/index.php accessed: 23.3.2010.
30. Kahi C J., Imperiale T F., Juliar B E. et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009 7 770-775; quiz 711
31. Brenner H, Hoffmeister M, Stegmaier C et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007 56 1585-1589
32. Ananda S S., McLaughlin S J., Chen F et al. Initial impact of Australias National Bowel Cancer Screening Program. Med J Aust 2009 191 378-381
33. Goodyear S J., Stallard N, Gaunt A et al. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study. Br J Surg 2008 95 1172-1179
34. Hoff G, Grotmol T, Skovlund E et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009 338 b1846
35. Parente F, Marino B, DeVecchi N et al. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg 2009 96 533-540
36. Mandel J S., Church T R., Bond J H. et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 343 1603-1607
37. www.gbe-bund.de Gesundheitsberichterstattung des Bundes Hrsg. Elektronische Ressource. Statistisches Bundesamt, Zweigstelle Bonn http://www.gbe-bund.de letzer Zugang am 9.4.2008
38. Edwards B K., Ward E, Kohler B A. et al. Annual report to the nation on the status of cancer, 1975 2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010 116 544-573
39. Winawer S J. A quarter century of colorectal cancer screening: progress and prospects. J Clin Oncol 2001 19 6S-12S